SUPT4H1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.160200E-01
Normal-vs-Stage2
2.147200E-01
Normal-vs-Stage3
2.550200E-01
Normal-vs-Stage4
4.125500E-02
Stage1-vs-Stage2
6.491800E-01
Stage1-vs-Stage3
7.587800E-01
Stage1-vs-Stage4
6.651600E-01
Stage2-vs-Stage3
3.789000E-01
Stage2-vs-Stage4
8.899800E-01
Stage3-vs-Stage4
5.506600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.505800E-01
Normal-vs-AfricanAmerican
4.277800E-02
Normal-vs-Asian
2.295200E-01
Caucasian-vs-AfricanAmerican
3.710600E-01
Caucasian-vs-Asian
8.391600E-01
AfricanAmerican-vs-Asian
5.316600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.575800E-01
Normal-vs-Female
2.553800E-01
Male-vs-Female
5.550800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.605000E-01
Normal-vs-Age(41-60Yrs)
4.796000E-01
Normal-vs-Age(61-80Yrs)
1.798400E-01
Normal-vs-Age(81-100Yrs)
1.055820E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.473800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.616000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.393000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.357300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.623030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.868600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.242200E-02
Normal-vs-Daily Drinker
2.926600E-01
Normal-vs-Weekly Drinker
1.912230E-01
Normal-vs-Occasional Drinker
5.959000E-01
Normal-vs-Social Drinker
4.102400E-01
Non Drinker-vs-Daily Drinker
3.248600E-01
Non Drinker-vs-Weekly Drinker
2.224200E-01
Non Drinker-vs-Occasional Drinker
2.303700E-02
Non Drinker-vs-Social Drinker
1.916170E-02
Daily Drinker-vs-Weekly Drinker
8.538800E-01
Daily Drinker-vs-Occasional Drinker
2.730000E-01
Daily Drinker-vs-Social Drinker
2.825800E-01
Weekly Drinker-vs-Occasional Drinker
3.469800E-01
Weekly Drinker-vs-Social Drinker
3.015600E-01
Occasional Drinker-vs-Social Drinker
9.347000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.317960E-01
Normal-vs-Grade 2
5.831800E-01
Normal-vs-Grade 3
5.582600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.856400E-01
Grade 1-vs-Grade 3
5.381000E-01
Grade 1-vs-Grade 4
1.317960E-01
Grade 2-vs-Grade 3
4.911800E-01
Grade 2-vs-Grade 4
5.831800E-01
Grade 3-vs-Grade 4
5.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.473580E-01
Normal-vs-NonDiabetic
3.370000E-01
Diabetic-vs-NonDiabetic
1.424440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.995580E-01
Normal-vs-NoPancreatitis
2.583600E-01
Pancreatitis-vs-NoPancreatitis
8.224400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.995600E-01
Normal-vs-N1
2.152800E-01
N0-vs-N1
3.016600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.512990E-01
Normal-vs-TP53-NonMutant
1.025680E-02
TP53-Mutant-vs-TP53-NonMutant
5.643000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
